Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pépin (Grenoble, France). Cluster analysis of clinical phenotypes of OSA and its implications for comorbidities. Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)

Member's Comments

No comment yet.

Related content which might interest you: Cluster analysis and clinical asthma phenotypes Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma. Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Stratifying COPD patients by cluster analysis using clinical and behavioral variables Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Cluster analysis to identify phenotypes in COPD Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Clinical COPD phenotypes identified by cluster analysis: validation with mortality Source: Eur Respir J 2012; 40: 495-496 Year: 2012 BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Clinical features and quality of life in patients with different metabolic phenotypes of COPD Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Source: Eur Respir J 2011; 38: 749-751 Year: 2011 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Clustering of adherence variability metrics and clinical outcomes in asthma Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Clinical characteristics and related risk factors of depression in patients with early COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Clinical COPD phenotypes: a novel approach using principal component and cluster analyses Source: Eur Respir J 2010; 36: 531-539 Year: 2010 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015